» Articles » PMID: 10807515

Cytokine Regulation of Liver Injury and Repair

Overview
Journal Immunol Rev
Date 2000 May 12
PMID 10807515
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

By comparing the hepatic responses to tumor necrosis factor (TNF)-alpha that occur during situations that promote liver injury (such as obesity or chronic exposure to ethanol) with those that occur after stimuli (such as partial hepatectomy) that lead to liver regeneration, it is apparent that hepatocytes are usually able to constrain noxious responses to TNF-alpha, such as the release of reactive oxygen from mitochondria. It appears that by promptly upregulating survival genes that regulate mitochondrial membrane permeability, hepatocytes are usually able to constrain noxious responses, including the release of mitochondrial-generated reactive oxygen species, that follow exposure to potentially toxic cytokines, such as TNF-alpha. Indeed, transient TNF-alpha-mediated increases in ROS may even be exploited by hepatocytes to evoke a subsequent proliferative response. Thus, the healthy liver has well-developed defense mechanisms that permit hepatocytes to adapt to cytokine-initiated stress, protecting them from cytokine-mediated lethality. Nevertheless, these same cytokines may cause liver injury when hepatocytes have been pre-exposed to toxins (e.g. ethanol) that interfere with their usual protective responses. Furthermore, while transient adaptations to cytokine-initiated stress permit hepatocytes to survive and proliferate, persistence of these anti-apoptotic, adaptative responses (as occurs, for example, in fatty livers) may inadvertently enhance hepatocyte vulnerability to necrosis when the liver is confronted by secondary insults that promote mitochondrial membrane depolarization.

Citing Articles

Morin hydrate ameliorates Di-2-ethylhexyl phthalate (DEHP) induced hepatotoxicity in a mouse model via TNF-α and NF-κβ signaling.

Kumar V, Kumar R, Gurusubramanian G, Rathore S, Roy V 3 Biotech. 2024; 14(7):181.

PMID: 38911474 PMC: 11189377. DOI: 10.1007/s13205-024-04012-8.


The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease.

Scarlata G, Colaci C, Scarcella M, Dallio M, Federico A, Boccuto L Diseases. 2024; 12(4).

PMID: 38667527 PMC: 11048950. DOI: 10.3390/diseases12040069.


Unconjugated hyperbilirubinemia may exacerbate certain underlying chronic liver diseases.

Dascal R, Uhanova J, Minuk G Can Liver J. 2023; 5(4):445-452.

PMID: 38144403 PMC: 10735202. DOI: 10.3138/canlivj-2022-0005.


MKP1 promotes nonalcoholic steatohepatitis by suppressing AMPK activity through LKB1 nuclear retention.

Qiu B, Lawan A, Xirouchaki C, Yi J, Robert M, Zhang L Nat Commun. 2023; 14(1):5405.

PMID: 37669951 PMC: 10480499. DOI: 10.1038/s41467-023-41145-5.


Post-hepatectomy biliary leaks: analysis of risk factors and development of a simplified predictive scoring system.

Patkar S, Kunte A, Sundaram S, Goel M Langenbecks Arch Surg. 2023; 408(1):63.

PMID: 36692605 DOI: 10.1007/s00423-023-02776-w.